Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-2017 | 05-2017 | 02-2017 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 2,533 | 0 | 0 |
| Receivables | 45 | 0 | 0 |
| Inventories | 67 | 0 | 0 |
| TOTAL | $2,796 | $0 | $0 |
| Non-Current Assets | |||
| PPE Net | 2 | N/A | N/A |
| Intangibles | 63 | 0 | 0 |
| TOTAL | $65 | $N/A | $N/A |
| Total Assets | $2,860 | $0 | $0 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 33 | 0 | 0 |
| Other current liabilities | 17 | 0 | 0 |
| TOTAL | $92 | $0 | $0 |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $92 | $0 | $0 |
| Shareholders' Equity | |||
| Common Shares | 68 | 0 | 0 |
| Retained earnings | -13,170 | 0 | 0 |
| Other shareholders' equity | -239 | 0 | 0 |
| TOTAL | $2,768 | $0 | $0 |
| Total Liabilities And Equity | $2,860 | $0 | $0 |